GlassScriptPhysician profile
Anthony K Leung
NPI 1205213287
$5,980.60
in general payments reported to CMS, 2019-2025
13 companies · $467 in 2025
The $467 reported for 2025 was more than what 77% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,079 · 2020: $538 · 2021: $257 · 2022: $275 · 2023: $1,447 · 2024: $918 · 2025: $467.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,831.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,831.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $1,931.05 | 2019-2024 | Senza |
| Medtronic, INC. | $1,185.96 | 2021-2025 | Intellis Adaptivestim, Inceptiv |
| Abbott Laboratories | $1,108.52 | 2019-2024 | Proclaim, Eterna |
| Boston Scientific Corporation | $531.96 | 2019-2025 | General - Pain Management |
| Avanos Medical | $394.79 | 2021-2025 | Generator |
| Spr Therapeutics, INC | $280.42 | 2023 | Sprint Pns System |
| Si-Bone, INC. | $157.44 | 2019-2023 | |
| Vertex Pharmaceuticals Incorporated | $115.63 | 2025 | |
| Teva Pharmaceuticals USA, INC. | $111.26 | 2019 | |
| Stryker Corporation | $67.13 | 2020-2025 | Mild Device Kit |
| Pacira Pharmaceuticals Incorporated | $36.00 | 2023 | Iovera, Zilretta, Exparel |
| Amgen INC. | $31.27 | 2019 | |
| Medtronic USA, INC. | $29.17 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Leung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.